General information | Instructions | Data extracted | ||||
First author | ||||||
Sponsorship trial | Copy any sponsorship mentioned in the article (usually bottom left, first page) | |||||
Methods | ||||||
Study design | RCT, quasi‐RCT, non‐randomised CCT | |||||
Method of randomisation | Tables, coin, etc | |||||
Allocation concealment | Closed envelopes, etc | |||||
Blindedness | ||||||
Population | ||||||
Place | Hospital/City/Country | |||||
Enrolment dates | Helps in finding out double‐reported populations | |||||
Inclusion criteria | ||||||
Exclusion criteria | ||||||
Age | Describe the age of the included population | |||||
Sex | Describe the sex distribution of the included population | |||||
Ethnicity | ||||||
Work status | ||||||
Duration of symptoms | ||||||
Previous treatments | ||||||
Total number of patients recruited | ||||||
Number of patients who met inclusion criteria | ||||||
Total number of patients randomised | ||||||
Total number of patients followed | ||||||
Interventions: | ||||||
Group 1 PCL (yes/no) Brand implant (manufacterer) Patella (yes/no) Bearing (mobile/fixed/rotating) Flexion space (how determined) |
You may copy the description of the intervention here, or simply indicate on which page and in which paragraph it can be found | PCL: Brand: Patella: Flexion space: |
||||
Group 2 | Idem | PCL: CR Brand: Patella: Flexion space: |
||||
Group 3 | Idem | PCL: Brand: Patella: Flexion space: |
||||
Outcomes | ||||||
Who carried out the measurement? | ||||||
What were the follow‐up moments? | Preop | 6 Months | 12 Months | 24 Months | ___Months | |
What was measured at each follow‐up and with which tool? ROM KSS functional KSS clinical VAS WOMAC KOOS OKS HSS IKDC Active flexion Passive flexion Revision Mortality SF‐36 Gait analysis Good Samaritan Knee Assessment Questionnaire |
||||||
Analysis: | ||||||
Statistical technique used: | Which tests? Alpha? Power? Sample size calculation? Software used? | Power: Sample size: Software: |
||||
Does technique adjust for confounding? | ||||||
Number (or %) followed‐up from each group: | ||||||
Results: | ||||||
Quantitative results | If no between‐group comparisons are given, then report here the general results | |||||
Qualitative results | ||||||
Adverse effects or complications | ||||||
1. Comparison: (A) .................. (N=) vs (B) .................... (N= ) Outcome: Follow‐up: preop (A): 0 (0) (B): 0 (0) 6 months (A): 0 (0) (B): 0 (0) 12 months (A): 0 (0) (B): 0 (0) 24 months (A): 0 (0) (B): 0 (0) X months (A): 0 (0) (B): 0 (0) 2. Comparison: (A) .................. (N=) vs (B) .................... (N= ) Outcome: Follow‐up: preop (A): 0 (0) (B): 0 (0) 6 months (A): 0 (0) (B): 0 (0) 12 months (A): 0 (0) (B): 0 (0) 24 months (A): 0 (0) (B): 0 (0) X months (A): 0 (0) (B): 0 (0) 3. Comparison: (A) .................. (N=) vs (B) .................... (N= ) Outcome: Follow‐up: preop (A): 0 (0) (B): 0 (0) 6 months (A): 0 (0) (B): 0 (0) 12 months (A): 0 (0) (B): 0 (0) 24 months (A): 0 (0) (B): 0 (0) X months (A): 0 (0) (B): 0 (0) 4. Comparison: (A) .................. (N=) vs (B) .................... (N= ) Outcome: Follow‐up: preop (A): 0 (0) (B): 0 (0) 6 months (A): 0 (0) (B): 0 (0) 12 months (A): 0 (0) (B): 0 (0) 24 months (A): 0 (0) (B): 0 (0) X months (A): 0 (0) (B): 0 (0) |